111 related articles for article (PubMed ID: 16799812)
1. Irinotecan changes gene expression in the small intestine of the rat with breast cancer.
Bowen JM; Gibson RJ; Cummins AG; Tyskin A; Keefe DM
Cancer Chemother Pharmacol; 2007 Feb; 59(3):337-48. PubMed ID: 16799812
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy.
Bowen JM; Gibson RJ; Tsykin A; Stringer AM; Logan RM; Keefe DM
Int J Cancer; 2007 Oct; 121(8):1847-56. PubMed ID: 17594691
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.
Al-Dasooqi N; Gibson RJ; Bowen JM; Logan RM; Stringer AM; Keefe DM
Exp Biol Med (Maywood); 2010 Oct; 235(10):1244-56. PubMed ID: 20682600
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
[TBL] [Abstract][Full Text] [Related]
5. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor.
Wang Y; Hu L; Yao R; Wang M; Crist KA; Grubbs CJ; Johanning GL; Lubet RA; You M
Oncogene; 2001 Nov; 20(53):7710-21. PubMed ID: 11753649
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan induces enterocyte cell death and changes to muc2 and muc4 composition during mucositis in a tumour-bearing DA rat model.
Thorpe D; Sultani M; Stringer A
Cancer Chemother Pharmacol; 2019 May; 83(5):893-904. PubMed ID: 30815720
[TBL] [Abstract][Full Text] [Related]
7. Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.
Vanhoecke B; Bateman E; Mayo B; Vanlancker E; Stringer A; Thorpe D; Keefe D
Exp Biol Med (Maywood); 2015 Jun; 240(6):725-41. PubMed ID: 25966981
[TBL] [Abstract][Full Text] [Related]
8. Role of p53 in irinotecan-induced intestinal cell death and mucosal damage.
Bowen JM; Gibson RJ; Stringer AM; Chan TW; Prabowo AS; Cummins AG; Keefe DM
Anticancer Drugs; 2007 Feb; 18(2):197-210. PubMed ID: 17159606
[TBL] [Abstract][Full Text] [Related]
9. Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the Dark Agouti rat.
Al-Dasooqi N; Bowen JM; Gibson RJ; Logan RM; Stringer AM; Keefe DM
Int J Exp Pathol; 2011 Oct; 92(5):357-65. PubMed ID: 21463374
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
Reinhold WC; Kouros-Mehr H; Kohn KW; Maunakea AK; Lababidi S; Roschke A; Stover K; Alexander J; Pantazis P; Miller L; Liu E; Kirsch IR; Urasaki Y; Pommier Y; Weinstein JN
Cancer Res; 2003 Mar; 63(5):1000-11. PubMed ID: 12615715
[TBL] [Abstract][Full Text] [Related]
11. Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study.
Al-Dasooqi N; Bowen J; Bennett C; Finnie J; Keefe D; Gibson R
Support Care Cancer; 2017 Feb; 25(2):391-398. PubMed ID: 27650103
[TBL] [Abstract][Full Text] [Related]
12. Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.
Gibson RJ; Bowen JM; Keefe DM
Int J Cancer; 2005 Sep; 116(3):464-70. PubMed ID: 15800945
[TBL] [Abstract][Full Text] [Related]
13. Selection of housekeeping genes for gene expression studies in a rat model of irinotecan-induced mucositis.
Al-Dasooqi N; Bowen JM; Gibson RJ; Logan RM; Stringer AM; Keefe DM
Chemotherapy; 2011; 57(1):43-53. PubMed ID: 21282945
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
Stringer AM; Gibson RJ; Bowen JM; Logan RM; Ashton K; Yeoh AS; Al-Dasooqi N; Keefe DM
Int J Exp Pathol; 2009 Oct; 90(5):489-99. PubMed ID: 19765103
[TBL] [Abstract][Full Text] [Related]
15. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?
Logan RM; Stringer AM; Bowen JM; Gibson RJ; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2009 Jan; 63(2):239-51. PubMed ID: 18351341
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells.
Minderman H; Conroy JM; O'Loughlin KL; McQuaid D; Quinn P; Li S; Pendyala L; Nowak NJ; Baer MR
Mol Cancer Ther; 2005 Jun; 4(6):885-900. PubMed ID: 15956246
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan-induced mucositis is associated with changes in intestinal mucins.
Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Laurence J; Keefe DM
Cancer Chemother Pharmacol; 2009 Jun; 64(1):123-32. PubMed ID: 18998135
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of gene expression patterns in an irinotecan-resistance colon cancer cell by cDNA microarray].
Chen X; Chen XZ; Liu M; Lang N; Tang QL; Chen J; Zhao XF; Bi F
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):15-8, 36. PubMed ID: 21355292
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.
Gibson RJ; Bowen JM; Inglis MR; Cummins AG; Keefe DM
J Gastroenterol Hepatol; 2003 Sep; 18(9):1095-100. PubMed ID: 12911669
[TBL] [Abstract][Full Text] [Related]
20. Reversal of severe methotrexate-induced intestinal damage using enteral n-3 fatty acids.
Koppelmann T; Pollak Y; Mogilner J; Bejar J; Coran AG; Sukhotnik I
Br J Nutr; 2013 Jan; 109(1):89-98. PubMed ID: 22456439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
